Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study

The purpose of this study is to estimate adherence to treatment in bipolar patients, to characterize patients based on adherence degree and to describe the variables linked to poor adherence to treatment in real-life practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bipolar Disorder Bipolar and Related Disorders Mental Disorders Mood Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Las Palmas, Gran Canarias, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients diagnosed with bipolar disorder I or II DSM-IV
Patients treated with at least one oral antipsychotic
Subjects able to read and write

Exclusion criteria

Patients participating in clinical trials

Treatment and study plan

Primary outcomes

Morisky-Green Scale

Time frame: Once, at the visit moment
Drug Attitude Inventory Scale (DAI-10)

Time frame: Once, at the visit moment

Secondary outcomes

Clinical Global Impressions for Bipolar illness-modified (CGI-BP-M)

Time frame: Once, at the visit moment
Functioning Assessment Short Test (FAST)

Time frame: Once, at the visit moment

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Important dates

Study start: 2009
Study completion: 2009
First posted: Jun 25, 2009
Registry last updated: Oct 30, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed